questionsmedicales.fr
Composés hétérocycliques
Composés hétéromonocycliques
Furanes
Furanes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Electronic Nicotine Delivery Systems
Diagnostic
5
Exposition professionnelle
Toxicologie
Analyse de sang
Analyse d'urine
Marqueurs biologiques
Furanes
Évaluation des risques
Exposition professionnelle
Symptômes
5
Effets à long terme
Troubles neurologiques
Système respiratoire
Irritation
Système immunitaire
Exposition prolongée
Prévention
5
Prévention
Équipements de protection
Mesures de sécurité
Ventilation
Industrie alimentaire
Contrôle de la température
Réglementations
Exposition professionnelle
Formation
Risques professionnels
Traitements
5
Antidotes
Traitement symptomatique
Irritation cutanée
Traitement topique
Soins d'urgence
Évaluation médicale
Complications
5
Complications
Troubles respiratoires
Cancers
Potentiel cancérigène
Reproduction
Développement fœtal
Système nerveux
Neuropathies
Facteurs de risque
5
Travailleurs
Industrie chimique
Pollution de l'air
Industries
Antécédents médicaux
Maladies respiratoires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Furanes : Questions médicales les plus fréquentes",
"headline": "Furanes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Furanes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-26",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Furanes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétéromonocycliques",
"url": "https://questionsmedicales.fr/mesh/D006573",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétéromonocycliques",
"code": {
"@type": "MedicalCode",
"code": "D006573",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "4-Butyrolactone",
"alternateName": "4-Butyrolactone",
"url": "https://questionsmedicales.fr/mesh/D015107",
"about": {
"@type": "MedicalCondition",
"name": "4-Butyrolactone",
"code": {
"@type": "MedicalCode",
"code": "D015107",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anhydrides citraconiques",
"alternateName": "Citraconic Anhydrides",
"url": "https://questionsmedicales.fr/mesh/D002949",
"about": {
"@type": "MedicalCondition",
"name": "Anhydrides citraconiques",
"code": {
"@type": "MedicalCode",
"code": "D002949",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Darunavir",
"alternateName": "Darunavir",
"url": "https://questionsmedicales.fr/mesh/D000069454",
"about": {
"@type": "MedicalCondition",
"name": "Darunavir",
"code": {
"@type": "MedicalCode",
"code": "D000069454",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.303"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Furfural",
"alternateName": "Furaldehyde",
"url": "https://questionsmedicales.fr/mesh/D005662",
"about": {
"@type": "MedicalCondition",
"name": "Furfural",
"code": {
"@type": "MedicalCode",
"code": "D005662",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.355"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lasalocide",
"alternateName": "Lasalocid",
"url": "https://questionsmedicales.fr/mesh/D007832",
"about": {
"@type": "MedicalCondition",
"name": "Lasalocide",
"code": {
"@type": "MedicalCode",
"code": "D007832",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anhydrides maléiques",
"alternateName": "Maleic Anhydrides",
"url": "https://questionsmedicales.fr/mesh/D008299",
"about": {
"@type": "MedicalCondition",
"name": "Anhydrides maléiques",
"code": {
"@type": "MedicalCode",
"code": "D008299",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.520"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Monensin",
"alternateName": "Monensin",
"url": "https://questionsmedicales.fr/mesh/D008985",
"about": {
"@type": "MedicalCondition",
"name": "Monensin",
"code": {
"@type": "MedicalCode",
"code": "D008985",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Naftidrofuryl",
"alternateName": "Nafronyl",
"url": "https://questionsmedicales.fr/mesh/D009257",
"about": {
"@type": "MedicalCondition",
"name": "Naftidrofuryl",
"code": {
"@type": "MedicalCode",
"code": "D009257",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.620"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrofuranes",
"alternateName": "Nitrofurans",
"url": "https://questionsmedicales.fr/mesh/D009581",
"about": {
"@type": "MedicalCondition",
"name": "Nitrofuranes",
"code": {
"@type": "MedicalCode",
"code": "D009581",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "3-(2-(5-Nitro-2-furyl)vinyl)-1,2,4-oxadiazol-5-amine",
"alternateName": "5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",
"url": "https://questionsmedicales.fr/mesh/D013184",
"about": {
"@type": "MedicalCondition",
"name": "3-(2-(5-Nitro-2-furyl)vinyl)-1,2,4-oxadiazol-5-amine",
"code": {
"@type": "MedicalCode",
"code": "D013184",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "N-(4-(5-Nitro-2-furyl)-1,3-thiazol-2-yl)formamide",
"alternateName": "FANFT",
"url": "https://questionsmedicales.fr/mesh/D005200",
"about": {
"@type": "MedicalCondition",
"name": "N-(4-(5-Nitro-2-furyl)-1,3-thiazol-2-yl)formamide",
"code": {
"@type": "MedicalCode",
"code": "D005200",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.290"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Furagine",
"alternateName": "Furagin",
"url": "https://questionsmedicales.fr/mesh/D005661",
"about": {
"@type": "MedicalCondition",
"name": "Furagine",
"code": {
"@type": "MedicalCode",
"code": "D005661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.308"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Furazolidone",
"alternateName": "Furazolidone",
"url": "https://questionsmedicales.fr/mesh/D005664",
"about": {
"@type": "MedicalCondition",
"name": "Furazolidone",
"code": {
"@type": "MedicalCode",
"code": "D005664",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.313"
}
}
},
{
"@type": "MedicalWebPage",
"name": "2-(Furan-2-yl)-3-(5-nitrofuran-2-yl)prop-2-énamide",
"alternateName": "Furylfuramide",
"url": "https://questionsmedicales.fr/mesh/D005668",
"about": {
"@type": "MedicalCondition",
"name": "2-(Furan-2-yl)-3-(5-nitrofuran-2-yl)prop-2-énamide",
"code": {
"@type": "MedicalCode",
"code": "D005668",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.330"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nifuratel",
"alternateName": "Nifuratel",
"url": "https://questionsmedicales.fr/mesh/D009545",
"about": {
"@type": "MedicalCondition",
"name": "Nifuratel",
"code": {
"@type": "MedicalCode",
"code": "D009545",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.410"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrofurantoïne",
"alternateName": "Nitrofurantoin",
"url": "https://questionsmedicales.fr/mesh/D009582",
"about": {
"@type": "MedicalCondition",
"name": "Nitrofurantoïne",
"code": {
"@type": "MedicalCode",
"code": "D009582",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.566"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrofural",
"alternateName": "Nitrofurazone",
"url": "https://questionsmedicales.fr/mesh/D009583",
"about": {
"@type": "MedicalCondition",
"name": "Nitrofural",
"code": {
"@type": "MedicalCode",
"code": "D009583",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.691"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrovin",
"alternateName": "Nitrovin",
"url": "https://questionsmedicales.fr/mesh/D009610",
"about": {
"@type": "MedicalCondition",
"name": "Nitrovin",
"code": {
"@type": "MedicalCode",
"code": "D009610",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ranitidine",
"alternateName": "Ranitidine",
"url": "https://questionsmedicales.fr/mesh/D011899",
"about": {
"@type": "MedicalCondition",
"name": "Ranitidine",
"code": {
"@type": "MedicalCode",
"code": "D011899",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Furanes",
"alternateName": "Furans",
"code": {
"@type": "MedicalCode",
"code": "D005663",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Anja Rahn",
"url": "https://questionsmedicales.fr/author/Anja%20Rahn",
"affiliation": {
"@type": "Organization",
"name": "Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Coffee Excellence Center & Analytical Technologies, Wädenswil, Switzerland. Electronic address: rahj@zhaw.ch."
}
},
{
"@type": "Person",
"name": "Chahan Yeretzian",
"url": "https://questionsmedicales.fr/author/Chahan%20Yeretzian",
"affiliation": {
"@type": "Organization",
"name": "Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Coffee Excellence Center & Analytical Technologies, Wädenswil, Switzerland. Electronic address: yere@zhaw.ch."
}
},
{
"@type": "Person",
"name": "Yinbo Wan",
"url": "https://questionsmedicales.fr/author/Yinbo%20Wan",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China."
}
},
{
"@type": "Person",
"name": "Haiyun Peng",
"url": "https://questionsmedicales.fr/author/Haiyun%20Peng",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China."
}
},
{
"@type": "Person",
"name": "Guisheng Deng",
"url": "https://questionsmedicales.fr/author/Guisheng%20Deng",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Electronic Nicotine Delivery Systems and Cardiovascular/Cardiometabolic Health.",
"datePublished": "2023-04-27",
"url": "https://questionsmedicales.fr/article/37104558",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1161/CIRCRESAHA.123.321565"
}
},
{
"@type": "ScholarlyArticle",
"name": "Smoking reduction using an electronic nicotine delivery system (ENDS) with nicotine delivery similar to combustible cigarettes.",
"datePublished": "2024-07-29",
"url": "https://questionsmedicales.fr/article/39075535",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12954-024-01064-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Smoking reduction using electronic nicotine delivery systems in combination with nicotine skin patches.",
"datePublished": "2023-07-17",
"url": "https://questionsmedicales.fr/article/37458789",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00213-023-06401-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Using varenicline in combination with electronic nicotine delivery systems (ENDS).",
"datePublished": "2023-08-07",
"url": "https://questionsmedicales.fr/article/37611481",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.drugalcdep.2023.110916"
}
},
{
"@type": "ScholarlyArticle",
"name": "Electronic nicotine delivery systems (ENDS): A convenient means of smoking?",
"datePublished": "2023-08-25",
"url": "https://questionsmedicales.fr/article/37634554",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.phrs.2023.106885"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétéromonocycliques",
"item": "https://questionsmedicales.fr/mesh/D006573"
},
{
"@type": "ListItem",
"position": 4,
"name": "Furanes",
"item": "https://questionsmedicales.fr/mesh/D005663"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Furanes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Furanes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Furanes",
"description": "Comment diagnostiquer une exposition aux furanes ?\nQuels tests sont utilisés pour détecter les furanes ?\nQuels symptômes indiquent une intoxication aux furanes ?\nY a-t-il des marqueurs biologiques pour les furanes ?\nComment évaluer le risque d'exposition aux furanes ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Electronic+Nicotine+Delivery+Systems#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Furanes",
"description": "Quels sont les symptômes d'une intoxication aiguë aux furanes ?\nLes furanes provoquent-ils des effets à long terme ?\nComment les furanes affectent-ils le système respiratoire ?\nY a-t-il des symptômes spécifiques chez les travailleurs exposés ?\nLes furanes affectent-ils le système immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Electronic+Nicotine+Delivery+Systems#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Furanes",
"description": "Comment prévenir l'exposition aux furanes ?\nQuelles mesures de sécurité doivent être mises en place ?\nLes furanes peuvent-ils être évités dans l'industrie alimentaire ?\nQuelles sont les réglementations concernant les furanes ?\nLes travailleurs doivent-ils être formés sur les furanes ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Electronic+Nicotine+Delivery+Systems#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Furanes",
"description": "Quel est le traitement de l'intoxication aux furanes ?\nDes antidotes existent-ils pour les furanes ?\nComment traiter les irritations cutanées causées par les furanes ?\nLes soins d'urgence sont-ils nécessaires en cas d'exposition ?\nQuel suivi médical est recommandé après exposition ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Electronic+Nicotine+Delivery+Systems#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Furanes",
"description": "Quelles complications peuvent survenir après exposition aux furanes ?\nLes furanes peuvent-ils causer des cancers ?\nComment les furanes affectent-ils la reproduction ?\nLes furanes peuvent-ils affecter le foie ?\nY a-t-il des effets sur le système nerveux ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Electronic+Nicotine+Delivery+Systems#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Furanes",
"description": "Qui est le plus à risque d'exposition aux furanes ?\nLes fumeurs sont-ils plus à risque d'exposition ?\nLes enfants sont-ils plus vulnérables aux furanes ?\nQuels facteurs environnementaux augmentent le risque ?\nLes personnes ayant des antécédents médicaux sont-elles à risque ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Electronic+Nicotine+Delivery+Systems#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une exposition aux furanes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques pour détecter des métabolites."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les furanes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour identifier les métabolites des furanes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication aux furanes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements, des douleurs abdominales et des vertiges."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques pour les furanes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des marqueurs comme le 2-furylméthylcétone peuvent être mesurés dans les fluides corporels."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque d'exposition aux furanes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation des conditions de travail et des sources potentielles d'exposition est nécessaire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication aiguë aux furanes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aigus incluent des maux de tête, des nausées, des irritations cutanées et respiratoires."
}
},
{
"@type": "Question",
"name": "Les furanes provoquent-ils des effets à long terme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition prolongée peut entraîner des effets chroniques comme des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Comment les furanes affectent-ils le système respiratoire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des irritations des voies respiratoires, des toux et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les travailleurs exposés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs peuvent présenter des symptômes comme des vertiges, des maux de tête et des troubles de la concentration."
}
},
{
"@type": "Question",
"name": "Les furanes affectent-ils le système immunitaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut altérer la réponse immunitaire, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux furanes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité au travail."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité doivent être mises en place ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des systèmes de ventilation adéquats et des formations sur les risques chimiques sont essentiels."
}
},
{
"@type": "Question",
"name": "Les furanes peuvent-ils être évités dans l'industrie alimentaire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en contrôlant les températures de cuisson et en évitant les méthodes de cuisson à haute température."
}
},
{
"@type": "Question",
"name": "Quelles sont les réglementations concernant les furanes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réglementations strictes existent pour limiter l'exposition professionnelle et environnementale."
}
},
{
"@type": "Question",
"name": "Les travailleurs doivent-ils être formés sur les furanes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation sur les risques et les mesures de sécurité est cruciale pour les travailleurs."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de l'intoxication aux furanes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste à retirer la source d'exposition et à gérer les symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les furanes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique et de soutien."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées causées par les furanes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé de rincer la zone affectée et d'appliquer des crèmes apaisantes ou corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils nécessaires en cas d'exposition ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en cas de symptômes graves, une évaluation médicale urgente est nécessaire."
}
},
{
"@type": "Question",
"name": "Quel suivi médical est recommandé après exposition ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier est conseillé pour surveiller les effets à long terme et la santé générale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition aux furanes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles respiratoires chroniques et des effets neurologiques."
}
},
{
"@type": "Question",
"name": "Les furanes peuvent-ils causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Comment les furanes affectent-ils la reproduction ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition peut entraîner des effets néfastes sur la reproduction et le développement fœtal."
}
},
{
"@type": "Question",
"name": "Les furanes peuvent-ils affecter le foie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition peut entraîner des lésions hépatiques et des troubles fonctionnels du foie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets sur le système nerveux ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut causer des troubles neurologiques, y compris des neuropathies."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition aux furanes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique et alimentaire sont les plus exposés aux furanes."
}
},
{
"@type": "Question",
"name": "Les fumeurs sont-ils plus à risque d'exposition ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter l'exposition aux furanes présents dans la fumée de cigarette."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables aux furanes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques des furanes en raison de leur développement."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux augmentent le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pollution de l'air et la proximité d'industries émettrices de furanes augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes ayant des antécédents médicaux sont-elles à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des antécédents de maladies respiratoires ou hépatiques sont plus à risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Coffee Excellence Center & Analytical Technologies, Wädenswil, Switzerland. Electronic address: rahj@zhaw.ch.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Coffee Excellence Center & Analytical Technologies, Wädenswil, Switzerland. Electronic address: yere@zhaw.ch.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China.
Key Laboratory of the Assembly and Application of Organic Functional Molecules of Hunan Province, Hunan Normal University, Changsha 410081, China.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China.
Key Laboratory of the Assembly and Application of Organic Functional Molecules of Hunan Province, Hunan Normal University, Changsha 410081, China.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China.
Key Laboratory of the Assembly and Application of Organic Functional Molecules of Hunan Province, Hunan Normal University, Changsha 410081, China.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
UR Molecular Systems, Department of Chemistry, University of Liège 4000 Liège Belgium fremacle@uliege.be.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Manchester Manchester M13 9PL UK.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
UR Molecular Systems, Department of Chemistry, University of Liège 4000 Liège Belgium fremacle@uliege.be.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
UR Molecular Systems, Department of Chemistry, University of Liège 4000 Liège Belgium fremacle@uliege.be.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
School of Chemical and Materials Sciences, Indian Institute of Technology Goa, GEC Campus Farmagudi Goa-403401 India rishikesh.narayan@iitgoa.ac.in.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
School of Chemical and Materials Sciences, Indian Institute of Technology Goa, GEC Campus Farmagudi Goa-403401 India rishikesh.narayan@iitgoa.ac.in.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
School of Chemical and Materials Sciences, Indian Institute of Technology Goa, GEC Campus Farmagudi Goa-403401 India rishikesh.narayan@iitgoa.ac.in.
School of Interdisciplinary Life Sciences, Indian Institute of Technology Goa GEC Campus, Farmagudi Goa-403401 India.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Department of Food Science and Biotechnology, Dongguk University-Seoul, 32, Dongguk-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 400-820 Republic of Korea.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
Department of Food Chemistry and Analytical Chemistry (170a), Institute of Food Chemistry, University of Hohenheim, 70599 Stuttgart, Germany.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
Chemisches und Veterinäruntersuchungsamt (CVUA) Karlsruhe, Weißenburger Straße 3, 76187 Karlsruhe, Germany.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
Department of Food Chemistry and Analytical Chemistry (170a), Institute of Food Chemistry, University of Hohenheim, 70599 Stuttgart, Germany. Electronic address: claudia.oellig@uni-hohenheim.de.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
School of Chemistry, University of Leeds, Leeds LS2 9JT, United Kingdom.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
Institute of Physical Chemistry, Karlsruhe Institute of Technology (KIT), Kaiserstr. 12, 76131 Karlsruhe, Germany.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
School of Chemistry, University of Leeds, Leeds LS2 9JT, United Kingdom.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
School of Chemistry, University of Leeds, Leeds LS2 9JT, United Kingdom.
National Centre for Atmospheric Science, School of Chemistry, University of Leeds, Leeds LS2 9JT, United Kingdom.
Publications dans "Furanes" :
The use of electronic nicotine delivery systems, specifically electronic cigarettes (e-cig), has risen dramatically within the last few years; the demographic purchasing these devices is now predomina...
Electronic nicotine delivery systems (ENDS) offer a promising approach to tobacco harm reduction, but many people use both ENDS and combustible cigarettes ("dual use"), which undermines potential risk...
Twenty-five cigarette smoking adults, not seeking smoking cessation treatment, but open to using ENDS as a cigarette substitute, were provided with a 12-week supply of BIDI...
Over 12 weeks, ENDS use increased to an average of 15.8 occasions per day (SD = 20.2) and self-reported cigarette consumption decreased by 82% from 16.7 cigarettes/day (SD = 6.0) at baseline to 3.0 ci...
In this study, the ENDS effectively replicated the subjective rewarding effects of participants' usual brands of cigarettes and led to a substantial reduction in reported cigarettes/day. Exhaled CO sh...
ClinicalTrials.gov identifier NCT05855343....
Electronic nicotine delivery systems (ENDS) are used by smokers seeking to reduce combustible cigarette (CC) use, but the role of nicotine replacement vs. behavioral and sensory factors is still poorl...
To assess the effects on smoking behavior of using nicotine vs. placebo ENDS in smokers using nicotine vs. placebo patches....
Ninety-four daily smokers were enrolled in a study that randomly assigned them to receive ENDS with nicotine vs. without nicotine and skin patches with vs. without nicotine. Smoking reduction and cess...
The use of nicotine in ENDS led to significant reductions in smoking (ENDS nicotine vs. placebo difference in CO change = -9.2 ppm; 90% CI (-1.5 ppm, -16.9 ppm)) and was highly correlated with reducti...
The presence of nicotine in ENDS was associated with a large reduction in smoking. Additional studies will be needed to determine whether there may be additive effects of nicotine ENDS and nicotine pa...
Varenicline is efficacious for smoking cessation, but a return to smokingusually occurs after treatment ends. Electronic nicotine delivery systems (ENDS) may enhance smoking reduction and cessation by...
Twenty-five individuals who smoked cigarettes, interested in switching but not seeking cessation treatment, received ENDS for 13 weeks; during weeks 2-13 they received varenicline. Assessments include...
Cigarette smoking decreased from 15.6 cigarettes/day (SD=5.6) at baseline to 2.8 cigarettes/day (SD=5.1) at week 13 (paired t(22)=10.24, p<0.0001). 28% of participants were confirmed to be abstinent i...
ENDS in combination with varenicline shows promise as a means to reduce dependence on cigarettes and facilitate switching from cigarettes to ENDS....
Electronic nicotine delivery systems (ENDS), which are becoming increasingly popular in many parts of the world, have recently become more sophisticated in terms of their more active content and bette...
Although over half of United States states have passed taxes on electronic nicotine delivery systems (ENDS), recent evidence links ENDS tax rates to increases in smoking, suggesting potentially substa...
Observational study of data from the Current Population Survey's 2010-2019 Tobacco Use Supplements....
The United States....
A total of 38 906 18 to 25 year-olds MEASUREMENTS: Multivariable linear regressions estimated two-way fixed effects analyses to assess ENDS and cigarette tax rates' relationships to recent and daily s...
A $1 increase in ENDS taxes yielded significant reductions in young adults' daily vaping (...
In the United States, higher ENDS tax rates are associated with decreased ENDS use but increased cigarette smoking among 18- to 25-year-olds, with associations reversed for cigarette taxes....
To identify, characterise and broadly synthesise factors associated with child and adolescent electronic nicotine delivery systems (ENDS) and/or electronic non-nicotine delivery systems (ENNDS) ever-u...
Four electronic databases were searched from inception to 3rd June 2022. Non-experimental studies that provided quantitative factors associated with adolescent and/or child ENDS or ENNDS ever-use and/...
The search of electronic databases identified 4756 records, 240 of which were included. The majority of studies examined factors categorised within the Biology and Personality domain of the Theory of ...
The evidence base on factors associated with ENDS/ENNDS use in children and adolescents is rapidly developing, predominately by research concentrated in high income regions and focused on behavioural-...
Responsiveness to drug-related cues assesses drug reward in research studies. There are currently no validated visual image cues related to electronic nicotine delivery systems (ENDS), thus, this stud...
ENDS users and non-vaping individuals in the United States and Canada were recruited via Amazon MTurk. A total of 120 ENDS-related images and 56 neutral images, matched for visual similarity, were ass...
After excluding patterned responses, the data from 926 participants (610 ENDS users, and 316 non-vaping controls) were analyzed. When viewing ENDS-related images, desire-to-vape scores were correlated...
Correlational findings of the affective ENDS-related images were similar to those of previous studies validating collections of tobacco and alcohol picture cues, supporting the future use of these sti...
The prevalence of electronic nicotine delivery systems (ENDS) use among US youths has increased significantly during the past decade. Identifying key factors highly associated with ENDS use is essenti...
To identify the most important risk factors in wave 4.5 (ie, December 2017 to December 2018) of the Population Assessment of Tobacco and Health Study (PATH) data that are associated with ENDS use in w...
This prognostic study examined data from waves 4.5 and 5 of the PATH youth data set using machine learning techniques. The PATH study is a nationally representative longitudinal cohort study of tobacc...
Wave 5 current ENDS use status of wave 4.5 adolescents who were tobacco-naive....
The analyzed data set comprised 7943 individuals who were tobacco-naive in wave 4.5. Among this group, 332 participants (4.2%) indicated their present use of ENDS in wave 5, 5047 (63.5%) were aged 12 ...
The findings of this study suggest that family and friends play an important role in ENDS use among adolescents. The top-ranking factors associated with ENDS use in this study are areas for further ex...
The combination of electronic nicotine delivery systems (ENDS) device and liquid characteristics affect user nicotine and toxicant exposure, however population-level national survey studies have not r...
U.S. adults (21+) using ENDS at least five days/week (n = 1,179) completed an online survey in 2020 and uploaded photos of their most used device and liquid. Device/liquid combinations were analyzed t...
Five device/liquid combinations accounted for 87 % of those reported. The most prevalent combination, reported by 36.2 %, was re-useable devices with adjustable settings and a tank refilled with a fre...
Analyzing ENDS device/liquid combinations rather than each separately can allow researchers to better evaluate relationships between use and key outcomes, such as quitting cigarettes and abuse liabili...